Intended Use

The ZEUS System (Zio Watch), as part of the Zio Watch Service, is intended to process and analyze electrocardiogram (ECG) and photoplethysmogram (PPG) based data to detect and report on the presence of Atrial Fibrillation (AF) over the monitoring period.

Technology

The ZEUS System is a software as a medical device (SaMD) consisting of modules that process ECG and PPG data collected from the Zio Watch wearable device. It uses machine learning algorithms—the ECG Deep Learned (ECGDL) software for ECG analysis and the AF Context Engine (ACE) for PPG data analysis—to generate preliminary findings for clinician reports. Results include AF detection and heart rate measurements, with technician quality review before reporting.

Performance

Performance, verification, and validation testing demonstrated conformance to FDA-recognized standards and that design requirements and intended use were met without raising new safety or efficacy issues. Algorithms were trained on continuous recordings annotated by Certified Cardiographic Technicians and validated on large datasets from ambulatory patients using simultaneous ECG and PPG recordings.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    10/19/2021

    9 months
  • 2

    FDA Approval

    7/19/2022

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.